Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NYKØBING F. DYREHOSPITAL ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.7% 1.1% 1.0% 1.1% 1.0% 1.1% 12.8% 12.8%   Credit score (0-100)   75 86 86 83 86 82 18 18   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   3.3 182.4 280.6 165.6 257.0 166.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,943 5,595 6,089 6,385 6,952 7,752 0.0 0.0   EBITDA   624 1,284 1,593 1,067 1,236 1,198 0.0 0.0   EBIT   393 1,097 1,405 888 1,074 1,055 0.0 0.0   Pre-tax profit (PTP)   391.8 1,092.3 1,392.8 875.7 1,057.3 1,052.8 0.0 0.0   Net earnings   288.5 853.8 1,086.5 681.3 820.8 817.8 0.0 0.0   Pre-tax profit without non-rec. items   392 1,092 1,393 876 1,057 1,053 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,025 2,174 1,986 1,807 1,645 1,897 0.0 0.0   Shareholders equity total   1,540 2,105 2,542 2,136 2,276 2,494 1,239 1,239   Interest-bearing liabilities   73.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,925 3,556 4,572 3,676 3,534 3,819 1,239 1,239   Net Debt   56.4 -547 -1,895 -1,191 -1,171 -835 -1,239 -1,239     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,943 5,595 6,089 6,385 6,952 7,752 0.0 0.0   Gross profit growth   -1.2% 13.2% 8.8% 4.9% 8.9% 11.5% -100.0% 0.0%   Employees   10 10 9 10 11 12 0 0   Employee growth %   11.1% 0.0% -10.0% 11.1% 10.0% 9.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,925 3,556 4,572 3,676 3,534 3,819 1,239 1,239   Balance sheet change%   -5.8% 21.6% 28.5% -19.6% -3.9% 8.1% -67.6% 0.0%   Added value   624.3 1,283.9 1,592.6 1,066.6 1,252.9 1,198.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -344 -38 -375 -358 -324 109 -1,897 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.0% 19.6% 23.1% 13.9% 15.4% 13.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   13.1% 34.3% 34.5% 21.5% 29.6% 28.7% 0.0% 0.0%   ROI %   20.4% 52.8% 54.5% 34.5% 43.9% 40.4% 0.0% 0.0%   ROE %   17.3% 46.8% 46.8% 29.1% 37.2% 34.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   52.6% 59.2% 55.6% 58.1% 64.4% 65.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   9.0% -42.6% -119.0% -111.7% -94.7% -69.7% 0.0% 0.0%   Gearing %   4.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.1% 49.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 0.6 1.2 1.1 1.5 1.1 0.0 0.0   Current Ratio   0.8 1.2 1.4 1.4 1.8 1.7 0.0 0.0   Cash and cash equivalent   17.4 546.6 1,895.4 1,191.1 1,171.2 835.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -249.8 185.3 798.4 561.5 855.6 820.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   62 128 177 107 114 100 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   62 128 177 107 112 100 0 0   EBIT / employee   39 110 156 89 98 88 0 0   Net earnings / employee   29 85 121 68 75 68 0 0